{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:10:47Z","timestamp":1791429047607,"version":"4.3.3"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.bcp.2017.05.020","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T06:00:14Z","timestamp":1496469614000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Ca v 1.2 channel current block by the PKA inhibitor H-89 in rat tail artery myocytes via a PKA-independent mechanism: Electrophysiological, functional, and molecular docking studies"],"prefix":"10.1016","volume":"140","author":[{"given":"Fabio","family":"Fusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia","family":"Spiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampietro","family":"Sgaragli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Bova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.05.020_b9000","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.81.20.6388","article-title":"Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state","volume":"81","author":"Bean","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2017.05.020_b9010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1476-5381.1996.tb16694.x","article-title":"Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculature","volume":"117","author":"Bova","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0005","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1016\/S0021-9258(19)34116-X","volume":"265","author":"Chijiwa","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.05.020_b0010","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0006-2952(01)00556-1","article-title":"Inhibition of Kv1.3 channels by H-89 (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) independent of protein kinase A","volume":"61","author":"Choi","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0015","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/CIRCRESAHA.111.240127","article-title":"Metabotropic regulation of RhoA\/Rho-associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction","volume":"108","author":"Fern\u00e1ndez-Tenorio","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2017.05.020_b9020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6793-12-9","article-title":"Contribution of transient and sustained calcium influx, and sensitization to depolarization-induced contractions of the intact mouse aorta","volume":"12","author":"Fransen","year":"2012","journal-title":"BMC Physiol."},{"key":"10.1016\/j.bcp.2017.05.020_b9030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1124\/jpet.109.161265","article-title":"Cardamonin is a bifunctional vasodilator that inhibits Cav1.2 current and stimulates KCa1.1 current in rat tail artery myocytes","volume":"332","author":"Fusi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2017.05.020_b9040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2012.01.038","article-title":"Mechanism of osthole inhibition of vascular Cav1.2 current","volume":"680","author":"Fusi","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00210-016-1266-y","article-title":"In vitro and in silico analysis of the vascular effects of asymmetrical N, N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents","volume":"389","author":"Fusi","year":"2016","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vph.2015.11.041","article-title":"The vasodilator papaverine stimulates L-type Ca2+ current in rat tail artery myocytes via a PKA-dependent mechanism","volume":"76","author":"Fusi","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2016.12.033","article-title":"The surge of flavonoids as novel, fine regulators of cardiovascular CaV channels","volume":"796","author":"Fusi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0035","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.1016\/S0021-9258(18)71718-3","article-title":"Protein kinase inhibitor-(6\u201322)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase","volume":"264","author":"Glass","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.05.020_b0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.pa.32.040192.002113","article-title":"Pharmacology of protein kinase inhibitors","volume":"32","author":"Hidaka","year":"1992","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2017.05.020_b9050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.33549\/physiolres.932000","article-title":"Measurement of cellular excitability by whole cell patch clamp technique","volume":"59","author":"Karma\u017e\u00ednov\u00e1","year":"2010","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bcp.2017.05.020_b9060","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","article-title":"Molecular determinants of drug binding and action on L-type calcium channels","volume":"37","author":"Hockerman","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2017.05.020_b0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0006-291X(87)90293-2","article-title":"K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases","volume":"42","author":"Kase","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2017.05.020_b0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.lfs.2006.09.029","article-title":"H-89 potentiates adipogenesis in 3T3-L1 cells by activating insulin signaling independently of protein kinase A","volume":"80","author":"Kato","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2017.05.020_b0060","doi-asserted-by":"crossref","first-page":"C1743","DOI":"10.1152\/ajpcell.2001.281.6.C1743","article-title":"Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a, b) by protein kinases","volume":"281","author":"Keef","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2017.05.020_b0065","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2017.05.020_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13321-016-0139-1","article-title":"AutoDock VinaXB: implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina","volume":"8","author":"Koebel","year":"2016","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bcp.2017.05.020_b0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0006-2952(97)00320-1","article-title":"Specific inhibition of cardiac and skeletal muscle sarcoplasmic reticulum Ca2+ pumps by H-89","volume":"54","author":"Lahouratate","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1527-3466.2006.00261.x","article-title":"The many faces of H89: a review","volume":"24","author":"Lochner","year":"2006","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.bcp.2017.05.020_b9075","first-page":"452","article-title":"Influence of depolarization on vasorelaxant potency and efficacy of Ca2+ entry blockers, K+ channel openers, nitrate derivatives, salbutamol and papaverine in rat aortic rings, Naunyn Schmiedeberg\u2019s Arch","volume":"358","author":"Magnon","year":"1998","journal-title":"Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/bj20020191","article-title":"Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase","volume":"364","author":"Mita","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2017.05.020_b0090","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bcp.2017.05.020_b0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/apha.12282","article-title":"L-type Ca2+ channel current characteristics are preserved in rat tail artery myocytes after one-day storage","volume":"211","author":"Mugnai","year":"2014","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bcp.2017.05.020_b0100","doi-asserted-by":"crossref","first-page":"re4","DOI":"10.1126\/scisignal.122re4","article-title":"Pharmacological PKA inhibition: all may not be what it seems","volume":"1","author":"Murray","year":"2008","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bcp.2017.05.020_b0105","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bbrc.2005.12.116","article-title":"The protein kinase A inhibitor, H-89, directly inhibits KATP and Kir channels in rabbit coronary arterial smooth muscle cells","volume":"340","author":"Park","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2017.05.020_b0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vph.2006.08.413","article-title":"Direct modulation of Ca(2+)-activated K(+) current by H-89 in rabbit coronary arterial smooth muscle cells","volume":"46","author":"Park","year":"2007","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2012.07.012","article-title":"H-89 decreases the gain of excitation-contraction coupling and attenuates calcium sparks in the absence of beta-adrenergic stimulation","volume":"691","author":"Parks","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0120","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.bjp.0706810","article-title":"H-89 inhibits transient outward and inward rectifier potassium currents in isolated rat ventricular myocytes","volume":"148","author":"Pearman","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0125","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(24)37973-X","article-title":"Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness","volume":"288","author":"Penn","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2017.05.020_b0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nmeth0408-277","article-title":"Cyclic nucleotide analogs as probes of signaling pathways","volume":"5","author":"Poppe","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bcp.2017.05.020_b0135","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00582316","article-title":"Rates of diffusional exchange between small cells and a measuring patch pipette","volume":"411","author":"Pusch","year":"1988","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2017.05.020_b0140","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1042\/bj2510757","article-title":"A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase","volume":"251","author":"Rothermel","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2017.05.020_b0145","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein-ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2017.05.020_b0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/bph.13369","article-title":"Functional, electrophysiological and molecular docking analysis of the modulation of Cav1.2 channels in rat vascular myocytes by murrayafoline A","volume":"173","author":"Saponara","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.05.020_b0155","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12038-013-9383-y","article-title":"Side-effects of protein kinase inhibitors on ion channels","volume":"38","author":"Son","year":"2013","journal-title":"J. Biosci."},{"key":"10.1016\/j.bcp.2017.05.020_b0160","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbrc.2006.01.053","article-title":"Direct inhibition of a PKA inhibitor, H-89 on KV channels in rabbit coronary arterial smooth muscle cells","volume":"341","author":"Son","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2017.05.020_b0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature19102","article-title":"Structural basis for inhibition of a voltage-gated Ca(2+) channel by Ca(2+) antagonist drugs","volume":"537","author":"Tang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2017.05.020_b0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00021.2003","article-title":"Localized effects of cAMP mediated by distinct routes of protein kinase A","volume":"84","author":"Task\u00e9n","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2017.05.020_b0175","doi-asserted-by":"crossref","first-page":"19006","DOI":"10.1074\/jbc.M109.011296","article-title":"Structural model for dihydropyridine binding to L-type calcium channels","volume":"284","author":"Tikhonov","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.05.020_b0180","first-page":"e2272v1","article-title":"Identification of \u201con-off residues\u201d in rat CaV1.2 \u03b11Csubunit channel using in silico analysis and docking simulation","volume":"4","author":"Trezza","year":"2016","journal-title":"PeerJ. Preprints"},{"key":"10.1016\/j.bcp.2017.05.020_b0185","doi-asserted-by":"crossref","first-page":"C651","DOI":"10.1152\/ajpcell.1995.268.3.C651","article-title":"Protein kinase inhibitor H-89 reverses forskolin stimulation of cardiac L-type calcium current","volume":"268","author":"Yuan","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bcp.2017.05.020_b0190","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217303222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217303222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:28:31Z","timestamp":1750289311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217303222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":45,"alternative-id":["S0006295217303222"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.05.020","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cav1.2 channel current block by the PKA inhibitor H-89 in rat tail artery myocytes via a PKA-independent mechanism: Electrophysiological, functional, and molecular docking studies","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}